Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
Reduced gamma-Catenin Expression and Poor Survival in Oral Squamous Cell Carcinoma
Archives of Otolaryngology, 10/26/09
Narkio–Makela M et al. – Reduced expression of gamma–catenin was associated with poor differentiation of OSCC, with neck lymph node metastases, and, more importantly, with poor disease–specific survival. Loss of gamma–catenin expression seems to contribute to metastatic properties of OSCC. Evaluation of the expression pattern of gamma–catenin may be useful for predicting outcome in patients with OSCC.
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer
Thyroid, 11/02/09
Today in Oral Cavity...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Allergy Syndrome
Allergology International, 10/30/09
Update on oral lichen planus
Expert Review of Dermatology, 10/14/09
Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update
Journal of Oral Pathology and Medicine, 11/24/09
Article Search
Sponsor


See Latest Articles


